Pressor support during a Jarisch Herxheimer reaction after initiation of treatment for Weil's disease

Randi Connor-Schuler1, Anee Khan1, Nikhil Goyal1

  • 1Henry Ford Hospital, Detroit, MI, USA.

Insights

Weil's disease can trigger a Jarisch-Herxheimer reaction (JHR) after antibiotic treatment, potentially causing severe decompensation. Patients require emergency department monitoring post-antibiotics for leptospirosis to manage this rare but serious complication.

Area of Science:

  • Infectious Diseases
  • Clinical Medicine
  • Pharmacology

Background:

  • Weil's disease, a severe form of leptospirosis, is caused by *Leptospira interrogans*.
  • Early antibiotic treatment is crucial for managing leptospirosis.
  • The Jarisch-Herxheimer reaction (JHR) is a known complication of treating spirochetal infections.

Observation:

  • A healthy young female presented with flu-like symptoms and jaundice after travel.
  • She received antibiotics for suspected leptospirosis in the emergency department.
  • The patient rapidly decompensated, requiring intensive care, including vasopressors.

Findings:

  • This case illustrates a rare Jarisch-Herxheimer reaction (JHR) complicating Weil's disease treatment.
  • Antibiotic initiation in leptospirosis can precipitate a severe JHR.
  • The reaction necessitated invasive monitoring and vasopressor support.

Implications:

  • Patients treated for leptospirosis/Weil's disease require close observation in the ED after antibiotic initiation.
  • Awareness of JHR is critical for timely recognition and management of decompensation.
  • This highlights the need for vigilance regarding potential adverse reactions to antibiotics in infectious disease management.

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
72
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
69
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
580
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
608
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K